Skip to main content

TC BioPharm (Holdings) plc

TCBPDelisted Aug 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001872812

TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.

Holders of 5% or more of TCBP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of TC BioPharm (Holdings) plc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of TC BioPharm (Holdings) plc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

7 Schedule 13D and 13G filings on TC BioPharm (Holdings) plc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TCBP
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 28, 2023Nipro Corp13GOld format–New–SEC
Feb 14, 2023Armistice Capital, LLC13GOld format–New–SEC
Jan 30, 2023MEDINET Co., Ltd.13GOld format–New–SEC
Jan 11, 2023Renaissance Capital Partners Ltd13D/AOld format–––SEC
Apr 27, 2022Renaissance Capital Partners Ltd13DOld format–New–SEC
Mar 17, 20224:49 PM ETAlta Partners LLC13GOld format–New–SEC
Feb 22, 20226:05 AM ETScottish Enterprise13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell TC BioPharm (Holdings) plc shares.

No Form 144 notices for TC BioPharm (Holdings) plc are on file.